Speaker Profile
MS, CGC, Head of Product, Mirvie
Biography
Carrie leads Mirvies efforts to develop the proprietary Mirvie RNA platform. The platform is first to predict unexpected complications months before symptoms occur by revealing the underlying biology of each pregnancy. It opens a new window into pregnancy health for women to act and their doctors to intervene before unexpected complications become a crisis. Mirvie is shaping the future of pregnancy health by enabling proactive, preventive, and personalized pregnancy care for the wellbeing of moms and babies. As a board certified genetic counselor, Carries direct patient care focused on high risk prenatal care and providing broad access to new diagnostic technologies. She led clinical teams at Massachusetts General Hospital and Sutter Health. Her direct clinical experience served as the foundation for leading edge product development at Counsyl, Myriad, and Miroculus.
Talk
Predicting Preeclampsia and Preterm Birth
Mirvie is developing the breakthrough Mirvie RNA platform to predict pregnancy complications months in advance, such as preeclampsia and preterm birth. We will present the company's landmark pregnancy health research, and show how the prediction of pregnancy complications can enable personalized care and the prevention of disease.
Clinical Dx Showcase:
Mirvie
Mirvie is shaping the future of pregnancy health by providing women, expecting parents and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
